A Randomized, Double-Blind, Placebo- and Active-Controlled, 4 Period Crossover Study To Evaluate the Effect of XP13512 on Cardiac Repolarization by Thorough Analysis of QTc Effect in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2012
At a glance
- Drugs Gabapentin enacarbil (Primary) ; Moxifloxacin
- Indications Diabetic neuropathies; Neuropathic pain; Restless legs syndrome
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 05 Nov 2010 New trial record.